Clinical Trials Logo

Clinical Trial Summary

Supracondylar femur fractures in the geriatric population present a unique challenge to the orthopaedic surgeon both in terms of fixation, healing, and final extremity axial alignment. Pulsed dosing of parathyroid hormone derivatives (Forteo) has been shown to increase bone mass, and several studies in Europe have demonstrated its benefit as an adjuvant for fracture healing. Abaloparatide represents a new compound which similarly offers great potential for accelerating fracture healing, especially healing associated with callous formation. This is a randomized, double blind placebo-controlled trial to compare a group of patients being treated for supracondylar distal femur fractures who receive abaloparatide (n=38) with a control group of patients who receive a placebo (n=38).


Clinical Trial Description

Supracondylar femur fractures in the geriatric population present a unique challenge to the orthopaedic surgeon both in terms of fixation, healing, and final extremity axial alignment. Multiple methods of fixation are well accepted, and each has its own advantages and disadvantages. The common occurrence of periprosthetic supracondylar femur fractures adds another level of complexity, and the universal goal when treating these patients is to obtain and maintain acceptable alignment, allow mobilization and early weight bearing, and achieve union. To a degree, mobilization and weight bearing compete with maintenance of axial alignment, and any final outcome is a race between healing and loss of fixation. As a result, any intervention that can accelerate healing would be of great benefit. As the vast majority of these injuries heal with secondary bone healing (callous), the determination of "healing" is reliably determined using the modified Radiographic Union Score for Tibia Fractures (mRUST), and thus this patient population offers an ideal population in which to evaluate an accelerant of fracture healing. Pulsed dosing of parathyroid hormone derivatives (Forteo) has been shown to increase bone mass, and several studies in Europe have demonstrated its benefit as an adjuvant for fracture healing. Abaloparatide represents a new compound which similarly offers great potential for accelerating fracture healing, especially healing associated with callous formation. This is a randomized, double blind placebo-controlled trial to compare a group of patients being treated for supracondylar distal femur fractures who receive abaloparatide (n=38) with a control group of patients who receive a placebo (n=38). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04626141
Study type Interventional
Source Geisinger Clinic
Contact
Status Withdrawn
Phase Phase 4
Start date June 2024
Completion date June 2025

See also
  Status Clinical Trial Phase
Completed NCT02272972 - Performance Improvement Program on Imaging II
Terminated NCT02679560 - Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures Phase 2
Terminated NCT00822159 - Influence of Bone Strength Measured by DensiProbe on Bone Related Fixation Failure N/A
Recruiting NCT05272631 - Depuy Synthes Lower Extremity Shaft Nail Registry
Recruiting NCT02672696 - Interest of Navigation for the Treatment of Pertrochanteric Fractures With the Gamma 3 Nail N/A
Terminated NCT01553630 - Reamed Locked Plating - Metaphyseal Fractures of the Distal Femur and Tibia N/A
Completed NCT00962910 - European Quality of Care Pathways Study on Proximal Femur Fracture (EQCP-PFF) N/A
Completed NCT00644397 - Plate Fixation of Distal Femur Fractures: A Protocol for a Study of Two Plate Options
Completed NCT05737459 - Sedation and Postoperative Cognitive Functions
Active, not recruiting NCT01599221 - Observational Retrospective and Prospective Study on the Treatment of Femoral Fractures With EBA2 N/A
Completed NCT00552331 - Evaluation of the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures Phase 4
Withdrawn NCT04865146 - A Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ (10S Models)
Recruiting NCT02658760 - Dexmedetomidine and Bupivacaine With Bupivacaine in Ultrasonography Guided Fascia Iliaca Compartment Block in Adults Phase 3
Completed NCT03800186 - Influence of Age on Trauma Femoral Fractures
Completed NCT01548456 - Nails Versus Plates for Femur Fractures in Dar es Salaam, Tanzania N/A
Completed NCT00509171 - Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism N/A
Completed NCT03822000 - Risk Factors and Complications Contributing to Mortality in Elderly Patients With Fall-Induced Femoral Fracture
Completed NCT06382584 - Impact of Treatment With Oral Anticoagulants of Patients With Fractures of the Upper End of the Femur
Completed NCT05172869 - Comparison of Two Different Approaches in the Fascia Iliaca Compartment Block in Femoral Fracture Surgery N/A
Terminated NCT01294098 - Efficacy Study of Femoral Nerve Block in Children With a Femur Fracture N/A